Plain-English translation of NCT06458075 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether training doctors to communicate better about lupus medications can help patients take their medicines consistently. Researchers will teach lupus specialists how to have supportive conversations about medication challenges, focusing on understanding your beliefs, concerns, and barriers to taking your medicines. The goal is to build trust between you and your doctor so you're more likely to stay on treatment and stay healthier.
Black patients with lupus often have a harder time staying on their medications, which can lead to worse health outcomes. This happens partly because conversations between patients and doctors about medication challenges don't happen regularly enough, and some patients feel their concerns aren't fully heard. This study aims to close that gap by training doctors to ask the right questions and listen more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll visit your lupus doctor as you normally would, and your doctor will have received special training on how to discuss your medications with you in a more supportive way. Your visit may be audio-recorded so researchers can see if the communication is improving. You may also fill out a brief questionnaire about your medication experiences. The study will follow your medication refill patterns over time to see if the doctor training makes a real difference in whether patients stay on their medicines.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States